Impact of Proviral-DNA M184V/I on 96-Week Outcomes of DTG/3TC Maintenance Therapy: Results From the VOLVER Clinical Trial

Journal:

Clinical Infectious Diseases

Published:

2026-02-10

DOI:

10.1093/cid/ciag060

Affiliations:

11

Authors:

18

Go to article

Institutions	Authors	Share
Biomedical Research Networking Center for Infectious Diseases (CIBERINFEC), Spain	4.000000	0.22
Instituto de Investigación Hospital 12 de Octubre (i+12), Spain	3.000000	0.17
Hospital La Paz Institute for Health Research (IdiPAZ), Spain	2.000000	0.11
Complutense University of Madrid (UCM), Spain	1.500000	0.08
Hospital Clinic of Barcelona, Spain	1.500000	0.08
Hospital Universitario de La Princesa, Spain	1.000000	0.06
Hospital del Mar, Spain	1.000000	0.06
Bellvitge Biomedical Research Institute (IDIBELL), Spain	1.000000	0.06
Prince of Asturias University Hospital, Spain	1.000000	0.06
University Hospital Alvaro Cunqueiro, Spain	1.000000	0.06
Fundación SEIMC-GESIDA (FSG), Spain	1.000000	0.06

Interested in Clinical Sciences?